Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cell, 2020
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Consiglio C., Cotugno N., Sardh F. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

The Journal of Clinical Endocrinology & Metabolism, 2020
Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes

Maalmi H., Herder C., Strassburger K. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologySerum

Translational Vision Science & Technology, 2020
Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy

Lamy R., Farber-Katz S., Vives F. et al.

Olink Target 96Metabolic DiseasesOphthalmologyTechnical EvaluationVitreous

Rheumatology, 2020
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment

Björk A., Da Silva Rodrigues R., Richardsdotter Andersson E. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Circulation, 2020
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease

Opstal T., Hoogeveen R., Fiolet A. et al.

Olink Target 96CVDPathophysiologySerum

Frontiers in Public Health, 2020
Exposure to Mild Steel Welding and Changes in Serum Proteins With Putative Neurological Function—A Longitudinal Study

Gliga A., Taj T., Wahlberg K. et al.

Olink Target 96Environmental Health & ToxicologyPatient StratificationSerum

Nature Reviews Genetics, 2020
Genetics meets proteomics: perspectives for large population-based studies

Suhre K., McCarthy M., Schwenk J.

Wider Proteomics StudiesReview/editorial

Cancers, 2020
Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome

Gyllensten U., Bosdotter Enroth S., Stålberg K. et al.

Olink Target 96Wider Proteomics StudiesEpidemiologyPlasma

Critical Care Explorations, 2020
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Fraser D., Cepinskas G., Patterson E. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Nature Medicine, 2020
An inflammatory cytokine signature predicts COVID-19 severity and survival

Del Valle D., Kim-Schulze S., Huang H. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Environmental Research, 2020
Association between prenatal immune phenotyping and cord blood leukocyte telomere length in the PRISM pregnancy cohort

Colicino E., Cowell W., Bozack A. et al.

Olink Target 96Environmental Health & ToxicologyInflammatory DiseasesPathophysiologySerum

Science Immunology, 2020
Natural killer cell immunotypes related to COVID-19 disease severity

Maucourant C., Filipovic I., Ponzetta A. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Proceedings of the National Academy of Sciences, 2020
Multiomic blood correlates of genetic risk identify presymptomatic disease alterations

Wainberg M., Magis A., Earls J. et al.

Olink Target 96Wider Proteomics StudiesPathophysiologyPlasma

Clinical Cancer Research, 2020
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Chong W., Lim C., Sinha A. et al.

Olink Target 96OncologyPatient StratificationPlasma

Frontiers in Immunology, 2020
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers

He H., Olesen C., Pavel A. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSkin Tape Strips

Clinical Research in Cardiology, 2020
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial

Ferreira J., Sharma A., Mehta C. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

European Heart Journal, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Wallentin L., Lindbäck J., Eriksson N. et al.

Olink Target 96CVDPathophysiologyPlasma

Science, 2020
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Arunachalam P., Wimmers F., Mok C. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

GSC Biological and Pharmaceutical Sciences, 2020
Susceptibility of men to SARS-CoV-2 may be caused by sex differences in ACE2 expression

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2020
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Rodriguez L., Pekkarinen P., Lakshmikanth T. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasmaSerum

1945 publications